Obesity, Morbid

Metabolic Diseases
1
Pipeline Programs
3
Companies
3
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
1
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

3 companies ranked by most advanced pipeline stage

Neuroelectrics
NeuroelectricsSpain - Barcelona
1 program
1
Cognitive TrainingPhase 21 trial
Active Trials
NCT03943979CompletedEst. Jun 2017
M&
Merck & Co.RAHWAY, NJ
1 program
Gut Hormone Profiling in Obese Patients With Type 2 Diabetes (MK-0000-134)N/A1 trial
Active Trials
NCT00957957Completed22Est. Nov 2014
Astellas
AstellasChina - Shenyang
1 program
laparoscopic sleeve gastrectomyN/A1 trial
Active Trials
NCT01913392Completed15Est. May 2018

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
NeuroelectricsCognitive Training
Astellaslaparoscopic sleeve gastrectomy
Merck & Co.Gut Hormone Profiling in Obese Patients With Type 2 Diabetes (MK-0000-134)

Clinical Trials (3)

Total enrollment: 37 patients across 3 trials

NCT03943979NeuroelectricsCognitive Training

Pilot Study of an Intervention Involving Cognitive Training and tDCS in Morbidly Obese Subjects

Start: Feb 2016Est. completion: Jun 2017
Phase 2Completed
NCT01913392Astellaslaparoscopic sleeve gastrectomy

Effect of Laparoscopic Sleeve Gastrectomy in the Morbidly Obese, Kidney Transplant Candidate

Start: Jul 2013Est. completion: May 201815 patients
N/ACompleted
NCT00957957Merck & Co.Gut Hormone Profiling in Obese Patients With Type 2 Diabetes (MK-0000-134)

Gut Hormone Profiling in Obese Patients With Type 2 Diabetes (MK-0000-134)

Start: Feb 2010Est. completion: Nov 201422 patients
N/ACompleted

Related Jobs in Metabolic Diseases

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

3 companies competing in this space